The Safety Net Foundation is a nonprofit foundation supported by Amgen that provides Amgen products at no cost to qualifying patients with no or limited drug coverage.  Products supported by The Safety Net Foundation include the following: Aranesp® (darbepoetin alfa), EPOGEN® (epoetin alfa), Neulasta® (pegfilgrastim), NEUPOGEN® (Filgrastim), Nplate® (romiplostim), Prolia® (denosumab), Sensipar® (cinacalcet), Vectibix® (panitumumab), and XGEVA® (denosumab).

Click here to go to www.safetynetfoundation.com.